Clinical trial · Interventional
Effect of Bra Use During Radiotherapy for Breast Cancer Radiotherapy
NCT06178861CI-TRIAL-00085557completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This prospective randomized study investigated the reproducibility of breast shape, radiation dose irradiated to the lungs, heart, dose distribution, patient satisfaction, and treatment toxicity when wearing and not wearing a bra during radiotherapy for patients with breast cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Radiation Therapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Group wearing a radiotherapy bra | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group wearing a bra
- description
- Patients wear a bra while receiving radiotherapy.
- interventionNames
- Device: Group wearing a radiotherapy bra
- type
- NO_INTERVENTION
- label
- Group not wearing a bra
- description
- Patients do not wear a bra while receiving radiotherapy.
Primary outcomes (1)
- measure
- The reproducibility of breast shape through cross-correlation values, both with and without the use of a bra
- timeFrame
- During the radiotherapy, an average of 1 month
- description
- Evaluating the reproducibility of breast shape through cross-correlation values in cone-beam CT and planning CT matching. This study involves comparing groups of patients wearing and not wearing a bra
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: 1. Patients with histologically confirmed invasive breast cancer or ductal carcinoma in situ 2. Patients eligible for whole breast irradiation after partial mastectomy 3. Adults over 20 years old 4. Patients with good overall performance (ECOG PS 0-1) Exclusion Criteria: 1. Recurrent breast cancer patients 2. Patients who have previously received radiation therapy to the ipsilateral breast 3. Patients who underwent breast reconstruction 4. Bilateral breast cancer 5. Patients with skin diseases such as contact dermatitis
References
Publications (1)
- DERIVEDByun HK, Kim H, Son J, Cho Y, Kwon YJ, Kim DW, Lee H, Kim YB. Impact of bra application in breast cancer radiotherapy: A pilot prospective randomized trial. Radiother Oncol. 2025 May;206:110785. doi: 10.1016/j.radonc.2025.110785. Epub 2025 Feb 12. PMID 39952437